These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 30342946)

  • 21. Mechanism of action and thrombolytic potential of staphylokinase.
    Lijnen HR
    Verh K Acad Geneeskd Belg; 1995; 57(4):303-14. PubMed ID: 8571666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of staphylokinase-derived nonadecapeptide on the activation of plasminogen.
    Okada K; Ueshima S; Matsuno H; Kawao N; Okamoto C; Tanaka M; Matsuo O
    Thromb Haemost; 2007 May; 97(5):795-802. PubMed ID: 17479190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NH2-terminal structural motifs in staphylokinase required for plasminogen activation.
    Schlott B; Gührs KH; Hartmann M; Röcker A; Collen D
    J Biol Chem; 1998 Aug; 273(35):22346-50. PubMed ID: 9712854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Staphylokinase: fibrinolytic properties and current experience in patients with occlusive arterial thrombosis.
    Collen D; Lijnen HR; Vanderschueren S
    Verh K Acad Geneeskd Belg; 1995; 57(3):183-96; discussion 196-8. PubMed ID: 7483814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of expression optimization of new derivative of staphylokinase (SAK-2RGD-TTI) with the rSAK.
    Faraji H; Ramezani M; Mashkani B; Sadeghnia HR; Benhangi HM; Hosseini Teshnizi S; Soltani F
    Biotechnol Prog; 2019 Jul; 35(4):e2819. PubMed ID: 30972956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cloning & expression of SAK enzyme from
    Muttar A; Numan IT
    J Med Life; 2022 Jun; 15(6):768-771. PubMed ID: 35928367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NMR secondary structure of the plasminogen activator protein staphylokinase.
    Ohlenschläger O; Ramachandran R; Flemming J; Gührs KH; Schlott B; Brown LR
    J Biomol NMR; 1997 Apr; 9(3):273-86. PubMed ID: 9204556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-based antigenic epitope and PEGylation improve the efficacy of staphylokinase.
    Xu Y; Shi Y; Zhou J; Yang W; Bai L; Wang S; Jin X; Niu Q; Huang A; Wang D
    Microb Cell Fact; 2017 Nov; 16(1):197. PubMed ID: 29137636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Staphylokinase requires NH2-terminal proteolysis for plasminogen activation.
    Schlott B; Gührs KH; Hartmann M; Röcker A; Collen D
    J Biol Chem; 1997 Feb; 272(9):6067-72. PubMed ID: 9038231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional properties of a novel mutant of staphylokinase with platelet-targeted fibrinolysis and antiplatelet aggregation activities.
    Chen H; Mo W; Zhang Y; Su H; Ma J; Yao R; Zhang S; Ge J; Song H
    Eur J Pharmacol; 2007 Jul; 566(1-3):137-44. PubMed ID: 17451675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of endothelial cells on activity of staphylokinase.
    Ueshima S; Okada K; Matsumoto H; Takaishi T; Fukao H; Matsuo O
    Blood Coagul Fibrinolysis; 1996 Jul; 7(5):522-9. PubMed ID: 8874862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetic and stoichiometric analysis of the modification process for N-terminal PEGylation of staphylokinase.
    Wang J; Hu T; Liu Y; Zhang G; Ma G; Su Z
    Anal Biochem; 2011 May; 412(1):114-6. PubMed ID: 21185800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction and characterization of a novel staphylokinase variant with thrombin-inhibitory activity.
    Wang M; Wang Y; Wang J; Zou M; Liu S; Xu T; Cai X; Wu C; Wang J; Xu D
    Biotechnol Lett; 2009 Dec; 31(12):1923-7. PubMed ID: 19685208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystal structure of a staphylokinase: variant a model for reduced antigenicity.
    Chen Y; Song G; Jiang F; Feng L; Zhang X; Ding Y; Bartlam M; Yang A; Ma X; Ye S; Liu Y; Tang H; Song H; Rao Z
    Eur J Biochem; 2002 Jan; 269(2):705-11. PubMed ID: 11856331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Split intein-mediated backbone cyclization enhances the stability and activity of staphylokinase, a potent fibrin-selective plasminogen activator.
    Baharian A; Ishida H; Sillner C; Vogel HJ
    Int J Biol Macromol; 2024 Jun; 275(Pt 1):133448. PubMed ID: 38945328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced plasminogen activation by staphylokinase in the presence of streptokinase beta/betagamma domains: plasminogen kringles play a role.
    Dahiya M; Rajamohan G; Dikshit KL
    FEBS Lett; 2005 Mar; 579(7):1565-72. PubMed ID: 15757642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel preparation protocol for the expression and purification of recombinant staphylokinase.
    Ren D; Li D; Yang W; Li Y; Gou X; Liang B; Li B; Wu Q
    Biotechnol Appl Biochem; 2008 Sep; 51(Pt 1):9-13. PubMed ID: 17967161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Staphylokinase Control of Staphylococcus aureus Biofilm Formation and Detachment Through Host Plasminogen Activation.
    Kwiecinski J; Peetermans M; Liesenborghs L; Na M; Björnsdottir H; Zhu X; Jacobsson G; Johansson BR; Geoghegan JA; Foster TJ; Josefsson E; Bylund J; Verhamme P; Jin T
    J Infect Dis; 2016 Jan; 213(1):139-48. PubMed ID: 26136471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New derivative of staphylokinase SAK-RGD-K2-Hirul exerts thrombolytic effects in the arterial thrombosis model in rats.
    Szemraj J; Zakrzeska A; Brown G; Stankiewicz A; Gromotowicz A; Grędziński T; Chabielska E
    Pharmacol Rep; 2011; 63(5):1169-79. PubMed ID: 22180359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet Membrane-Coated r-SAK Improves Thrombolytic Efficacy by Targeting Thrombus.
    Hua R; Li M; Lin Q; Dong M; Gong X; Lin Z; Li Y; Li C; Wu T; Tan C; Zhang W; Wang Q; Wu T; Zhou X; Yang F; Li C
    ACS Appl Mater Interfaces; 2024 May; 16(17):21438-21449. PubMed ID: 38626407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.